Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US9011897 | ZUREX PHARMA | Catheter lock solution comprising citrate and a paraben |
Feb, 2025
(1 year, 10 months from now) | |
US8226971 | ZUREX PHARMA | Catheter lock solution comprising citrate and a paraben |
May, 2025
(2 years from now) | |
US8703828 | ZUREX PHARMA | Antimicrobial compositions and methods of use |
May, 2028
(5 years from now) | |
US9629368 | ZUREX PHARMA | Antimicrobial compositions and methods of use |
May, 2028
(5 years from now) | |
US8389583 | ZUREX PHARMA | Antimicrobial compositions and methods of use |
Aug, 2029
(6 years from now) | |
US10688291 | ZUREX PHARMA | Medical skin applicator apparatus |
Dec, 2034
(11 years from now) | |
US9844654 | ZUREX PHARMA | Medical skin applicator apparatus |
Apr, 2036
(13 years from now) |
Exclusivity | Exclusivity Expiration |
---|---|
M (M) | Jun 24, 2024 |
Market Authorisation Date: 26 April, 2019
Treatment: Use as an antiseptic for the preparation of a patient's skin prior to surgery
Dosage: SOLUTION;TOPICAL
14
United States
5
Mexico
5
China
4
Australia
4
Russia
4
European Union
3
Denmark
3
Brazil
3
Spain
3
Poland
3
Japan
3
Canada
2
Israel
2
South Africa
2
Hong Kong
1
Austria
1
Slovenia
1
Germany
1
Portugal
1
Korea, Republic of
1
Chile
1
New Zealand
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic